中兽医医药杂志
中獸醫醫藥雜誌
중수의의약잡지
Journal of Traditional Chinese Veterinary Medicine
2012年
1期
12-15
,共4页
李华%聂芳红%林红英%张继东%马驿%巨向红%陈进军
李華%聶芳紅%林紅英%張繼東%馬驛%巨嚮紅%陳進軍
리화%섭방홍%림홍영%장계동%마역%거향홍%진진군
千里光提取物冻干粉%耳肿胀度抑制率%抗炎作用%药物代谢动力学%小鼠
韆裏光提取物凍榦粉%耳腫脹度抑製率%抗炎作用%藥物代謝動力學%小鼠
천리광제취물동간분%이종창도억제솔%항염작용%약물대사동역학%소서
frozen powder of Sertecio sca~xt~rts extract%ear tumefaction inhibitory rate%anti-inflammatory action%pharmacokinetics%mouse
为了探索千里光提取物冻干粉(SsE)的药物代谢动力学特征,首次采用耳肿胀度抑制率药理效应法测定SsE药动学参数。结果发现,在一定剂量范围内给小鼠腹腔注射SsE,能较迅速地产生药理效应,使耳肿胀度抑制率显著提高;SsE最低有效量为57.40mg/kg,在小鼠体内代谢符合一级反应一室模型,模型表达式为:c=1436.227e^(-0.1334t)-1436.227e^(-0.237t),表观药动学参数为:一级消除速率常数Ke=0.1334h^-1,消除半衰期tlm=5.1949h,一级吸收速率常数Ka=0.237h^-1,吸收半衰期tv2ka=2.9241h,血药峰浓度cmax=1436.227mg,Icg,达峰时间tmnx=5.5474h,清除率CI=0.0553mg/kg·h,药一时曲线下面积AUC=16826.35mg/kg·h,表观分布容积V=O.4142mg/kg,滞后期to=0.0104h。表明SsE具有良好的抗炎作用,在小鼠体内起效快,消除慢,生物利用度高,在机体内分布有限,较集中于血浆,组织摄入少。
為瞭探索韆裏光提取物凍榦粉(SsE)的藥物代謝動力學特徵,首次採用耳腫脹度抑製率藥理效應法測定SsE藥動學參數。結果髮現,在一定劑量範圍內給小鼠腹腔註射SsE,能較迅速地產生藥理效應,使耳腫脹度抑製率顯著提高;SsE最低有效量為57.40mg/kg,在小鼠體內代謝符閤一級反應一室模型,模型錶達式為:c=1436.227e^(-0.1334t)-1436.227e^(-0.237t),錶觀藥動學參數為:一級消除速率常數Ke=0.1334h^-1,消除半衰期tlm=5.1949h,一級吸收速率常數Ka=0.237h^-1,吸收半衰期tv2ka=2.9241h,血藥峰濃度cmax=1436.227mg,Icg,達峰時間tmnx=5.5474h,清除率CI=0.0553mg/kg·h,藥一時麯線下麵積AUC=16826.35mg/kg·h,錶觀分佈容積V=O.4142mg/kg,滯後期to=0.0104h。錶明SsE具有良好的抗炎作用,在小鼠體內起效快,消除慢,生物利用度高,在機體內分佈有限,較集中于血漿,組織攝入少。
위료탐색천리광제취물동간분(SsE)적약물대사동역학특정,수차채용이종창도억제솔약리효응법측정SsE약동학삼수。결과발현,재일정제량범위내급소서복강주사SsE,능교신속지산생약리효응,사이종창도억제솔현저제고;SsE최저유효량위57.40mg/kg,재소서체내대사부합일급반응일실모형,모형표체식위:c=1436.227e^(-0.1334t)-1436.227e^(-0.237t),표관약동학삼수위:일급소제속솔상수Ke=0.1334h^-1,소제반쇠기tlm=5.1949h,일급흡수속솔상수Ka=0.237h^-1,흡수반쇠기tv2ka=2.9241h,혈약봉농도cmax=1436.227mg,Icg,체봉시간tmnx=5.5474h,청제솔CI=0.0553mg/kg·h,약일시곡선하면적AUC=16826.35mg/kg·h,표관분포용적V=O.4142mg/kg,체후기to=0.0104h。표명SsE구유량호적항염작용,재소서체내기효쾌,소제만,생물이용도고,재궤체내분포유한,교집중우혈장,조직섭입소。
Abstract: To explore the pharmaeokinetic characteristics of the frozen powder of Senecio scamtens extract ( SsE ), the model with the method of anti-inflammatory pharmacological effect was employed and the pharmacokinetic parameters were determined. The results showed that intraperitoneal injection with SsE could significantly inhibit the tumefaction of the mouse ear very fast, the minimal effective dose of SsE was 57.40 mg/kg, the distribution of SsE in the mice was coincident with the first grade responsive and single compartment model, and the pharmacok inetics model was C= I 436.227 e^ (-0.133 4 t) -1436.227 e^ (-0.237 t), with the parameters as Ke=0.133 4 h-^-1, h1/2ke=5.194 9 h, Ka= 0.237 h-1, h1/2ka=2.924 I h, Cmax=1436.227mg·kg-1, tmax=5.547 4 h, C1=0.055 3 mg·kg-1·h-1, AUC=I6 826.35 mg·'kg-1·h, V=0.414 2 mg·kg-1, t0=0.010 4 h. It indicated that SsE performed relatively good anti-inflammation effect with a quick-action and higher-bioavailability but slow-elimination model, which was resuhed from the very limited distribution in tissues but mainly in plasma.